Grey Matters Health Inc. AGNPF
The SEC does not publish structured financial data (XBRL) for Grey Matters Health Inc., so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jun 26, 2026 | — |
| D/A | Filing | Dec 9, 2025 | — |
| D | Filing | Dec 1, 2025 | — |
| D | Filing | Apr 10, 2024 | — |
| RW | Form rw | Dec 21, 2022 | — |
| F-1/A | Form f-1/a | Jun 3, 2022 | — |
| FWP | Free writing prospectus | May 10, 2022 | — |
| F-1/A | Form f-1/a | May 9, 2022 | — |
| F-1/A | Form f-1/a | Apr 25, 2022 | — |
| F-1/A | Form f-1/a | Apr 15, 2022 | — |
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AGNPF (OTC)
- Fiscal year ends
- August 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Vancouver
- SEC CIK
- 1642178
- Former names
- Algernon Health Inc. (until Dec 9, 2025); Algernon Pharmaceuticals Inc. (until Apr 10, 2024); Breathtec Biomedical, Inc. (until Oct 26, 2018); Breathtec BioMedical, Inc. (until Oct 26, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.